Drug-Eluting Stents vs. Drug-Coated Balloons in the SFA: How I Decide
Presenter
Jun Li, M.D., FSCAI, University Hospitals Harrington Heart & Vascular Institute, Parma, OH
Jun Li, M.D., FSCAI, University Hospitals Harrington Heart & Vascular Institute, Parma, OH
Learning Objectives:
- Review comparative data of drug-coated technologies in the femoropopliteal segment.
- Describe factors that influence device selection (DES vs. DCB) in femoropopliteal interventions.
Keywords: Peripheral Artery Disease (PAD) and Superficial Femoral Artery (SFA)